AI주식인사이트AI Stock Insight
B

진바이오텍

086060KOSDAQ

60.5 / 100

Reference Date: 2026-09-08

Financial Score28.0 / 40
News Sentiment12.5 / 25
Momentum10.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but Operating Profit is on a declining trend. Slightly up 1.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

JinbioTech operates in two segments: producing functional feed additives and manufacturing animal pharmaceuticals through its subsidiary DaeWon Chemical. The industry faces growing demand for eco-friendly and natural products, requiring technological innovation to overcome challenges like antibiotic resistance. The market benefits from the stable growth of the livestock sector, ensuring consistent demand for its products.

Number of Employees

45people

Average Salary

44.8M KRW

Score Calculation Basis

Detailed Financial Score

PER
11.11Industry Average 15.006.5Point

Lower than industry avg (good)

PBR
0.77Industry Average 1.205.5Point

Lower than industry avg (good)

ROE
7.15Industry Average 8.002.5Point

Below industry avg

Debt Ratio
8.95Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20255.5 / 10 points
Revenue Growth Rate
2.0 / 3

Avg ▲6.9% (2-year basis)

Operating Profit Growth Rate
0.5 / 3

Avg ▼0.4% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 6.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position6.0Point

52w upper range (79%)

Current 4,890Won52-week high 5,23052-week low 3,600
1-month return3.0Point

1m 1.14% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14
  • Neutral주식등의대량보유상황보고서(일반)2026-08-10